Tutorials
OTCPK:LMLLF (Canada)  
Pharmadrug Inc logo

Pharmadrug Inc

$ 0.02 -0.003325 (-12.4%) 11:08 PM EST
P/E:
At Loss
P/B:
0.77
Market Cap:
$ 8.30M
Enterprise V:
$ 7.68M
Volume:
2.05K
Avg Vol (2M):
101.33K
Also Trade In:
Volume:
2.05K
Market Cap $:
8.30M
PE Ratio:
At Loss
Avg Vol (2-Month):
101.33K
Enterprise Value $:
7.68M
PB Ratio:
0.77
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Pharmadrug Inc
NAICS : 325411 SIC : 3741
77 King Street West, Suite 2905, Toronto, ON, CAN, M5K 1H1
Description
Pharmadrug Inc operates as a vertically integrated business in the medical cannabis industry. The company's only segment being the distribution of medical cannabis in Germany. Geographically, it operates in Germany and Canada.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.31
Equity-to-Asset 0.85
Debt-to-Equity 0.06
Debt-to-EBITDA -0.16
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -0.1
Distress
Grey
Safe
Beneish M-Score -3.07
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 59.6
3-Year EPS without NRI Growth Rate 60.1
3-Year FCF Growth Rate 48.3

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 44.7
9-Day RSI 50.21
14-Day RSI 50.17
6-1 Month Momentum % -32.79
12-1 Month Momentum % -57.32

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.07
Quick Ratio 0.87
Cash Ratio 0.48
Days Inventory 97.19
Days Sales Outstanding 26.07
Days Payable 323.14

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -122.2

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 24.68
Operating Margin % -1149.13
Net Margin % -1286.8
ROE % -33.36
ROA % -28.87
ROIC % -26.2
ROC (Joel Greenblatt) % -7958.92
ROCE % -33.77

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 33.77
PB Ratio 0.77
EV-to-EBIT -1.79
EV-to-EBITDA -2.22
EV-to-Revenue 26.42
EV-to-FCF -3.24
Earnings Yield (Greenblatt) % -55.66

Financials

LMLLF's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with OTCPK:LMLLF

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.367
EPS (TTM) ($) -0.026
Beta 2.61
Volatility % 54.71
14-Day RSI 50.17
14-Day ATR ($) 0.003959
20-Day SMA ($) 0.021993
12-1 Month Momentum % -57.32
52-Week Range ($) 0.0144 - 0.07
Shares Outstanding (Mil) 353.34

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Pharmadrug Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More